| Primary |
| Factor Viii Deficiency |
55.0% |
| Haemophilia |
11.3% |
| Haemorrhage |
4.5% |
| Drug Use For Unknown Indication |
4.1% |
| Prophylaxis |
3.6% |
| Haemarthrosis |
2.7% |
| Pain |
2.7% |
| Haemorrhage Prophylaxis |
1.8% |
| Hepatitis C |
1.8% |
| Immune Tolerance Induction |
1.8% |
| Disseminated Intravascular Coagulation |
1.4% |
| Haemostasis |
1.4% |
| Hypertension |
1.4% |
| Product Used For Unknown Indication |
1.4% |
| Acquired Haemophilia |
0.9% |
| Adrenal Insufficiency |
0.9% |
| Convulsion Prophylaxis |
0.9% |
| Haematoma |
0.9% |
| Hemophilia A |
0.9% |
| Kidney Rupture |
0.9% |
|
| Anti Factor Viii Antibody Positive |
15.1% |
| Factor Viii Inhibition |
9.7% |
| Haemorrhage |
9.7% |
| Haematuria |
6.5% |
| Hallucination, Visual |
6.5% |
| Hepatitis C Antibody Positive |
6.5% |
| No Adverse Event |
6.5% |
| Splenomegaly |
5.4% |
| Drug Ineffective |
4.3% |
| Muscle Haemorrhage |
4.3% |
| Pyrexia |
4.3% |
| Weight Increased |
4.3% |
| Alopecia |
2.2% |
| Convulsion |
2.2% |
| Hepatic Enzyme Increased |
2.2% |
| Hypersensitivity |
2.2% |
| Joint Swelling |
2.2% |
| Ligament Operation |
2.2% |
| Mass |
2.2% |
| Medication Error |
2.2% |
|
| Secondary |
| Factor Viii Deficiency |
76.6% |
| Haemophilia |
5.8% |
| Prophylaxis |
3.8% |
| Haemorrhage |
3.0% |
| Disseminated Intravascular Coagulation |
1.4% |
| Haemostasis |
1.4% |
| Pneumonia |
1.0% |
| Sedation |
1.0% |
| Shock Haemorrhagic |
0.8% |
| Transfusion |
0.8% |
| Convulsion Prophylaxis |
0.6% |
| Immune Tolerance Induction |
0.6% |
| Rhinitis Allergic |
0.5% |
| Circulatory Collapse |
0.5% |
| Kidney Rupture |
0.4% |
| Colectomy |
0.4% |
| Hypertension |
0.4% |
| Tooth Extraction |
0.4% |
| Pain |
0.3% |
| Reduction Of Increased Intracranial Pressure |
0.3% |
|
| Haemorrhage |
20.4% |
| Hepatitis C Antibody Positive |
20.1% |
| Anti Factor Viii Antibody Positive |
18.0% |
| Haematuria |
12.6% |
| Factor Viii Inhibition |
6.6% |
| Renal Haemorrhage |
2.8% |
| Gastric Ulcer Haemorrhage |
2.6% |
| Haemophilia |
2.1% |
| Head Injury |
2.1% |
| Pyrexia |
1.7% |
| Vomiting |
1.7% |
| Chest Pain |
1.4% |
| Pharmaceutical Product Complaint |
1.4% |
| Wrong Technique In Drug Usage Process |
1.4% |
| Renal Injury |
1.2% |
| Splenomegaly |
1.2% |
| Anaphylactic Reaction |
0.7% |
| Unevaluable Event |
0.7% |
| Wound Infection |
0.7% |
| Drug Ineffective |
0.5% |
|
| Concomitant |
| Hiv Infection |
55.4% |
| Product Used For Unknown Indication |
28.6% |
| Hepatitis C |
8.9% |
| Haemophilia |
5.4% |
| Coagulation Factor Viii Level |
1.8% |
|
| Gastrointestinal Haemorrhage |
28.6% |
| Death |
14.3% |
| Hepatic Cirrhosis |
14.3% |
| Hyperthermia |
14.3% |
| Pyrexia |
14.3% |
| Small Intestine Carcinoma |
14.3% |
|
